Genetic Polymorphism of the Nrf2 Promoter Region (rs35652124)‎ Is Associated with the Risk of Diabetic Foot Ulcers

Abstract EN

The genetic polymorphism in the nuclear factor erythroid 2-related factor 2 (Nrf2) gene has been reported as one of the prognosis markers for various diseases, including cancer.

Nrf2 is a key transcription factor involved in wound healing by regulating angiogenesis.

We investigated the genetic association of NRF2 single-nucleotide polymorphism rs35652124 with T2DM and DFU and assessed its functional impact.

A total of 400 subjects were recruited for the study and categorized into three groups: infected DFU patients (DFU, n=100), T2DM patients without complications (T2DM, n=150), and healthy adults with normal glucose tolerance (NGT, n=150).

The subjects were genotyped by PCR-RFLP, and the polymorphism was identified by bidirectional Sanger sequencing.

The expression of NRF2, IL-10, TNF-α, and IL-6 was studied by qPCR to evaluate the functional impact of rs35652124.

The “TT” genotype of rs35652124 was associated with a significant risk for T2DM [OR=2.2 (1.2-4.2), p=0.01] and DFU [OR=7.9 (4-14.9), p<0.0001].

A significant decrease in transcriptional levels of NRF2 and IL-10 and a remarkable increase in TNF-α and IL-6 were observed in subjects with TT genotype.

In conclusion, rs35652124 (TT) is a harmful genetic variant that predisposes to insulin resistance and impaired angiogenesis.

Hence, it may serve as a diagnostic genetic marker for T2DM and DFU in combination with different inflammatory markers.